Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics.
AMA J Ethics. 2021;23(5):E405-409. doi:
10.1001/amajethics.2021.405.
Violence reduction efforts should be modeled on noncontagious diseases, which have as their root cause environmental determinants, not contagious diseases.
AMA J Ethics. 2018;20(5):513-515. doi:
10.1001/journalofethics.2018.20.5.corr1-1805.
Gary Slutkin, MD, Charles Ransford, MPP, and Daria Zvetina
Violence reduction efforts should focus on interrupting transmission of violence and changing behaviors rather than mitigating environmental risk factors.
AMA J Ethics. 2018;20(5):516-519. doi:
10.1001/journalofethics.2018.20.5.corr2-1805.
Nicole D. Damari, MS, Karan S. Ahluwalia, Anthony J. Viera, MD, MPH, and Adam O. Goldstein, MD, MPH
Continuing medical education (CME) attendance on gun safety is associated with firearm safety counseling and asking patients with depression about guns.
AMA J Ethics. 2018;20(1):56-68. doi:
10.1001/journalofethics.2018.20.1.stas1-1801.
Public health surveillance for infectious disease provides a model for a mandatory reporting policy for human trafficking, which poses risks for survivors.
AMA J Ethics. 2017;19(1):45-53. doi:
10.1001/journalofethics.2017.19.1.stas1-1701.
Targeted dosing to treat pediatric inflammatory bowel disease is challenging because dosing guidelines are based on data gathered from adult subjects of clinical trials. Patients’ families and health care organizations also incur high costs and must try to balance potential benefits against risks of ongoing monitoring.
AMA J Ethics. 2018;20(9):E841-848. doi:
10.1001/amajethics.2018.841.
Introduction of an intervention that reduces the perceived risk of a given behavior may cause a person to increase risky behavior—this is called “risk compensation.”